S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Critical asset just had biggest fall on record (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Critical asset just had biggest fall on record (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Critical asset just had biggest fall on record (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Critical asset just had biggest fall on record (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
AT&T will give $5 to customers hit by cellphone network outage
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

$1.05
-0.05 (-4.55%)
(As of 02/23/2024 ET)
Today's Range
$1.05
$1.16
50-Day Range
$0.74
$1.40
52-Week Range
$0.70
$5.10
Volume
19,061 shs
Average Volume
29,930 shs
Market Capitalization
$9.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Biotricity MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.36mentions of Biotricity in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.66) to ($0.55) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.51 out of 5 stars


BTCY stock logo

About Biotricity Stock (NASDAQ:BTCY)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY Stock Price History

BTCY Stock News Headlines

A sudden and dramatic change is coming to US bank accounts.
The financial elite (and US government) has a major change planned. It could strange new changes applied to your bank, overnight.
Billionaires Are Now FLOODING Into Gold
Ray Dalio, John Paulson, and many others all recommend you own gold right now. But did you know there's another huge investor (worth more than all the world's billionaires COMBINED) buying gold by the ton? That's why the best move to make right now could be this little-known gold investment (which you can get started with for just $5).
See More Headlines
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/25/2024
Fiscal Year End
3/31/2024
Next Earnings (Estimated)
7/04/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:BTCY
Fax
N/A
Employees
55
Year Founded
N/A

Profitability

Net Income
$-18,660,000.00
Net Margins
-125.43%
Pretax Margin
-125.43%

Debt

Sales & Book Value

Annual Sales
$9.64 million
Book Value
($3.24) per share

Miscellaneous

Free Float
6,813,000
Market Cap
$9.00 million
Optionable
Optionable
Beta
1.39
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Waqaas Al-Siddiq Ph.D. (Age 39)
    Founder, President, CEO & Chairman
    Comp: $732k
  • Mr. S. John Ayanoglou (Age 57)
    Chief Financial Officer
    Comp: $305.75k
  • Mr. Andy Wong
    Vice President of Operations
  • Dr. George N. Nikopoulos
    Director of Business Development
  • Mr. Matt Zabel
    Vice President of Sales & Strategy
  • Mr. Amir Ali
    Chief Development Officer














BTCY Stock Analysis - Frequently Asked Questions

Should I buy or sell Biotricity stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biotricity in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" BTCY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BTCY, but not buy additional shares or sell existing shares.
View BTCY analyst ratings
or view top-rated stocks.

How have BTCY shares performed in 2024?

Biotricity's stock was trading at $1.15 at the beginning of the year. Since then, BTCY shares have decreased by 8.7% and is now trading at $1.05.
View the best growth stocks for 2024 here
.

Are investors shorting Biotricity?

Biotricity saw a drop in short interest in January. As of January 31st, there was short interest totaling 111,200 shares, a drop of 11.3% from the January 15th total of 125,400 shares. Based on an average trading volume of 26,600 shares, the short-interest ratio is currently 4.2 days. Approximately 1.5% of the shares of the stock are short sold.
View Biotricity's Short Interest
.

When is Biotricity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024.
View our BTCY earnings forecast
.

When did Biotricity IPO?

(BTCY) raised $15 million in an initial public offering (IPO) on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

Who are Biotricity's major shareholders?

Biotricity's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.20%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BTCY) was last updated on 2/25/2024 by MarketBeat.com Staff